VNRX,VolitionRx Limited | Healthcare

Healthcare

VNRX

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

VolitionRx LimitedVNRX

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide.

It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes.

The company is based in Henderson, Nevada.

Latest News >

VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

Nov 11, 2025

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. ( VSEE ) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authorization to deliver secure, scalable telehealth services to federal agencies and beyond. In a bold step forward, VSee is integrating advanced robotic assistance into intensive care units (ICUs), enabling remote clinicians...

Tenzai Raises $75 Million in Record Seed Round to Build an AI Hacker That Secures Code Written By AI

Nov 11, 2025

Founded by veteran offensive cyber experts, Tenzai introduces an AI agentic penetration testing platform that actively hacks, exploits, and fixes hardest-to-find vulnerabilities across enterprise software at the speed of AI. TEL AVIV, IL / ACCESS Newswire / November 11, 2025 / Tenzai, the AI-native cybersecurity company redefining penetration testing through autonomous, agentic AI, today announced its launch out of stealth...

How To Earn $500 A Month From Disney Stock Ahead Of Q4 Earnings

Nov 11, 2025

The Walt Disney Company ( DIS ) will release fourth-quarter earnings before the opening bell on Thursday, Nov. 13. Analysts expect the media conglomerate to report quarterly earnings at $1.02 per share. That’s down from $1.14 per share in the year-ago period. The consensus estimate for Disney's ( DIS ) quarterly revenue is $22.78 billion (Benzinga Pro shows $22.57 billion...

Earnings Cycles Bolster The Unique Relevance Of ProShares Nasdaq-100 High Income ETF

Nov 11, 2025

While every earnings season allows publicly traded companies to deliver market-shifting news, an underlying dynamic exists that many (if not most) retail investors are largely unaware of. For optionable securities, the derivatives arena often sees heightened expectations of stock movement known as implied volatility (IV). This metric is often stacked against the historic (or realized) volatility, which measures how much...